Premier Pharmacy Labs has voluntarily recalled several lots of injectable drug products, primarily opioid pain relievers, due to possible microbial contamination, the Food and Drug Administration announced yesterday. Hospitals and other health care facilities should stop using and return any recalled products to the company as described in a certified letter sent to all affected customers. Any adverse reactions or quality problems experienced with the products may be reported to the FDA's MedWatch program.

Related News Articles

Headline
Hospitals spend close to $360 million each year to manage drug shortages, according to a study released this week by Vizient Inc.
Headline
The Centers for Disease Control and Prevention this week announced an anticipated shortage of Aplisol, one of two TB skin tests licensed by the Food and Drug…
Headline
A federal court in Texas yesterday ordered Pharm D Solutions to stop producing or distributing compounded drugs intended to be sterile until the company…
Headline
The Food and Drug Administration Friday issued final guidance clarifying how sponsors may show that a proposed biosimilar product is interchangeable with a…
Headline
The House Judiciary Committee yesterday approved by voice vote the Creating and Restoring Equal Access to Equivalent Samples Act (H.R. 965).
Headline
Civica Rx, the not-for-profit generic drug company, officially opened its headquarters last week in Lehi, Utah.